Prime Medicine (PRME) Other Operating Expenses (2023)

Prime Medicine (PRME) posted Other Operating Expenses of $13.5 million for Q4 2023.

Prime Medicine (PRME) Other Operating Expenses (2023) Analysis & Trends

Prime Medicine's Other Operating Expenses history runs 1 years deep, the most recent figure standing at $13.5 million for Q4 2023.

Quarterly Other Operating Expenses changed N/A year-over-year to $13.5 million in Q4 2023, while the trailing twelve-month figure through Sep 2024 was $13.5 million (changed N/A YoY) and the FY2023 annual result came in at $13.5 million, changed N/A from the prior year.
Other Operating Expenses was $13.5 million for Q4 2023 at Prime Medicine.
Across five years, Other Operating Expenses topped out at $13.5 million in Q4 2023 and bottomed at $13.5 million in Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn
7	Belite Bio	61.40 Bn	61.40 Bn	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn
9	Revolution Medicines	37.37 Bn	37.37 Bn	-
10	Prime Medicine	524.20 Mn	524.20 Mn	-

Download Data

Date	Value
Dec 31, 2023	13.50 Mn